Home
HelpTest Code LAB5008 Lyme Disease Screen, Serum
Additional Codes
| Test Name in EPIC | EPIC Test Code | Mnemonic |
|---|---|---|
| LYME DISEASE SCR | LAB5008 | LYMES |
Methodology
Chemiluminescence Immunoassay (CLIA)
Specimen Requirements
Specimen Type: Serum
Container/Tube: Serum gel
Specimen Volume: 2 mL
Specimen Minimum Volume: 1 mL
Collection Instructions: Grossly hemolyzed or lipemic specimen is not acceptable.
Additional Information: Avoid repeated freeze/thaw cycles.
Specimen Transport Temperature
Refrigerate 5 days/Frozen 2 months OK/Ambient NO
Day(s) Test Set Up
Monday through Friday (once daily)
Performing Laboratory
| Minnesota |
|---|
| SMDC Clinical Lab (Duluth) |
Test Classification and CPT Coding
86618
Reference Values
Negative: < 0.90
Equivocal: ≥ 0.90 - < 1.10
Positive: ≥ 1.10
Testing Algorithm
This panel utilizes FDA-cleared assays following the modified 2-tier testing (MTTT) algorithm to aid in the diagnosis of Lyme disease in individuals with clinical signs and symptoms consistent with Lyme disease. Lyme disease should be considered based on the presence of typical signs and symptoms of infection in patients with a history of possible exposure to infected ticks.
Specimens are tested using an immunoassay measuring total antibodies to specific borrelial proteins; if equivocal or reactive results are obtained, the specimens will automatically reflex to separate IgG and IgM immunoassays targeting additional Borrelia burgdorferi proteins.
No further confirmatory testing will be performed upon completion of the MTTT algorithm.